Tuberculosis News Media Resources

Recent Releases

Updated Recommendations for TB Screening, Testing and Treatment of U.S. Health Care Personnel – May 16, 2019

Historically, U.S. health care personnel were at increased risk for latent TB infection (LTBI) and TB disease from occupational exposures, but recent data suggest that this is no longer the case. CDC and the National Tuberculosis Controllers Association have updated the 2005 CDC recommendations for health care personnel.

Media Summary |  MMWR | Graphics


CDC Releases Preliminary 2018 TB Data – March 21, 2019

Preliminary 2018 data, released today in advance of World TB Day, show that while TB case counts are the lowest on record, there is slowed progress toward TB elimination.

Media Summary | Graphics | MMWR


CDC Releases Updated Recommendations for Treatment of Latent TB Infection – June 28, 2018

CDC released updated recommendations for use of once-weekly isoniazid-rifapentine for 12 weeks (3HP) for treatment of latent TB infection. The updated recommendations support expanded use of an effective, shorter, treatment regimen to reach even more people with latent TB infection.

Media Summary  |   Graphics  |   MMWR  | Fact Sheetpdf icon


Tuberculosis continues to decline in the U.S., but progress toward elimination is slowing – March 22, 2018

Preliminary 2017 data, released today in advance of World TB Day, show that while TB case counts reached a record low in 2017, the rate of decline is too slow to eliminate TB during this century.

Press Release | Fact Sheetpdf icon | MMWR | Graphics | Audio Clips

Fast Facts
  • 2018 preliminary data show that 9,029 TB cases were reported in the U.S. Cases declined slightly between 2017 and 2018 by -0.7% this progress is too slow to eliminate TB in this century.
  • TB continues to occur in every state and region in the U.S. with a 2018 incidence rate of 2.8 new cases per 100,000 people.
  • The nation’s TB elimination goal is less than one case per million people. Currently, there are 28 cases per million people in the U.S.
TB Expert
Dr. Philip LoBue

Philip LoBue, MD, FACP, FCCP
Director, Division of Tuberculosis Elimination
View Dr. LoBue's full bio

Page last reviewed: September 6, 2016